1. P001 Safety, tolerability, and efficacy of 1 month of atomoxetine plus oxybutynin in obstructive sleep apnoea. (7th October 2021) Authors: Aishah, A; Loffler, K; Tonson, B; Mukherjee, S; Adams, R; Altree, T; Ainge-Allen, H; Yee, B; Grunstein, R; Taranto-Montemurro, L; Carberry, J; Eckert, D Journal: Sleep advances Issue: Volume 2:Supplement 1(2021) Page Start: A22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O001 Reboxetine reduces obstructive sleep apnea severity: a randomized trial. (7th October 2021) Authors: Altree, T; Aishah, A; Loffler, K; Grunstein, R; Eckert, D Journal: Sleep advances Issue: Volume 2:Supplement 1(2021) Page Start: A1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P002 Targeted non-CPAP combination therapy resolves obstructive sleep apnoea. (7th October 2021) Authors: Aishah, A; Tong, B; Osman, A; Donegan, M; Pitcher, G; Kwan, B; Brown, L; Altree, T; Adam, R; Mukherjee, S; Eckert, D Journal: Sleep advances Issue: Volume 2:Supplement 1(2021) Page Start: A22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P009 The effects of low-dose morphine on sleep and breathlessness in chronic obstructive pulmonary disease. (9th November 2022) Authors: Altree, T; Loffler, K; Toson, B; Currow, D; Eckert, D Journal: Sleep advances Issue: Volume 3(2022)Supplement 1 Page Start: A34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗